Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo

Peng Sun,1,2 Qichang Yang,1 Yanben Wang,2 Jiaxuan Peng,3 Kangxian Zhao,1 Yewei Jia,2 Tan Zhang,2 Xuanyuan Lu,2 Weiqi Han,2 Yu Qian1,2 1The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, People’s Republic of China...

Full description

Bibliographic Details
Main Authors: Sun P, Yang Q, Wang Y, Peng J, Zhao K, Jia Y, Zhang T, Lu X, Han W, Qian Y
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Drug Design, Development and Therapy
Subjects:
osteoclast
osteoporosis
erk
jnk
akt
pri
Online Access:https://www.dovepress.com/pristimerin-inhibits-osteoclast-differentiation-and-bone-resorption-in-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/pristimerin-inhibits-osteoclast-differentiation-and-bone-resorption-in-peer-reviewed-article-DDDT

Similar Items